N. Yoshimura et al., THE EXPRESSION AND LOCALIZATION OF FIBROBLAST GROWTH-FACTOR-I (FGF-1)AND FGF RECEPTOR-1 (FGFR-1) IN HUMAN BREAST-CANCER, Clinical immunology and immunopathology (Print), 89(1), 1998, pp. 28-34
Fibroblast growth factor-1 (FGF-1) is an inducer of angiogenesis, the
growth of new blood vessels. The expression and localization of FGF-1
(acidic FGF) and FGF receptor (FGFR)-1 in mammary tissues from patient
s with breast cancer was investigated using Western blot analysis and
immunohistochemistry. The affinity-purified FGF-1 antibody which did n
ot have cross-reactivity to FGF-2 (basic FGF) was used in this study,
Western blot analysis demonstrated the presence of FGF-1 protein in al
l of the samples from breast cancer, but not benign tumors such as mas
topathy and fibroadenoma. To assess the localization of FGF-1 in cance
r tissues, immunostaining with specific antibody was performed. AU sam
ples from breast cancer displayed significantly intense staining with
FGF-1 antibody. The extent and intensity of immunoreactive FGF-1 polyp
eptides in cancer cells was statistically much greater than those of c
ells from fibroademoma or mastopathy. Control immunostaining with norm
al rabbit serum or anti-FGF-1 antibody adsorbed with the recombinant F
GF-1 polypeptide was completely negative. In contrast to PGF-1, Wester
n blot analysis demonstrated the presence of FGFR-1 protein in all of
the samples from breast cancer and benign tumors. By immunohistochemic
al analysis, the enhanced expression of FGFR-1 was observed in breast
cancer cells. Benign tumor cells or interstitial cells displayed a fai
nt expression of FGFR-1. These results demonstrated that breast cancer
cells not only generated FGF-1, but also expressed FGFR-1, and FGF-1
might play a role in the proliferation of breast cancer cells not only
by paracrine but also by autocrine mechanism. (C) 1998 Academic Press
.